Level Biotechnology Inc.
3118.TWO- 1D
- -2.4%
Level Biotechnology Inc. in brief
Level Biotechnology Inc. is a listed company in the Biotechnology industry, based in Taiwan. Its market value was $29 M on 19 November 2026, which makes it the 23,214th largest listed company in the world and the 1,678th largest in Taiwan on this site. Its shares trade under the symbol 3118.TWO (Taiwan).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
Level Biotechnology Inc. timeline
- 2008
- 📈Listed on Taipei Exchange as 3118First day of listing in the exchange's official list.
Events of Level Biotechnology Inc. from the exchanges' official lists. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Level Biotechnology Inc. share price · Taiwan (3118.TWO)
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Nov 19, 2026 | 29.50 | 29.55 | 28.90 | 28.90 | -2.4% | 91,000 |
| Nov 18, 2026 | 29.90 | 30.10 | 29.50 | 29.60 | -1.2% | 50,000 |
| Nov 17, 2026 | 30.00 | 30.00 | 29.60 | 29.95 | -0.5% | 19,000 |
| Nov 16, 2026 | 30.50 | 30.50 | 29.90 | 30.10 | +0.3% | 25,000 |
| Nov 13, 2026 | 30.15 | 30.45 | 29.95 | 30.00 | -0.7% | 19,000 |
| Nov 12, 2026 | 30.15 | 30.35 | 30.15 | 30.20 | +0.2% | 15,000 |
| Nov 11, 2026 | 30.10 | 30.45 | 30.10 | 30.15 | -1.5% | 5,000 |
| Nov 10, 2026 | 30.25 | 30.60 | 30.20 | 30.60 | +1.0% | 26,000 |
| Nov 9, 2026 | 30.30 | 30.50 | 30.30 | 30.30 | 0.0% | 6,000 |
| Nov 6, 2026 | 30.30 | 30.45 | 30.20 | 30.30 | -0.3% | 13,000 |
| Nov 5, 2026 | 30.15 | 30.40 | 30.15 | 30.40 | 0.0% | 8,000 |
| Nov 4, 2026 | 31.00 | 31.00 | 30.10 | 30.40 | -0.7% | 25,000 |
| Nov 3, 2026 | 30.35 | 30.95 | 30.10 | 30.60 | 0.0% | 30,000 |
| Oct 30, 2026 | 30.55 | 30.60 | 30.55 | 30.60 | -0.2% | 3,000 |
| Oct 29, 2026 | 30.60 | 30.80 | 30.60 | 30.65 | +0.2% | 4,000 |
| Oct 28, 2026 | 30.65 | 30.70 | 30.60 | 30.60 | 0.0% | 5,000 |
| Oct 27, 2026 | 30.60 | 30.60 | 30.60 | 30.60 | -0.6% | 5,000 |
| Oct 22, 2026 | 30.65 | 30.80 | 30.65 | 30.80 | 0.0% | 3,000 |
| Oct 21, 2026 | 30.70 | 31.00 | 30.40 | 30.80 | +0.3% | 11,000 |
| Oct 20, 2026 | 31.50 | 31.50 | 30.70 | 30.70 | 0.0% | 9,000 |
| Oct 19, 2026 | 30.80 | 30.90 | 30.60 | 30.70 | -0.3% | 15,000 |
| Oct 16, 2026 | 30.90 | 31.05 | 30.80 | 30.80 | -0.3% | 26,000 |
| Oct 15, 2026 | 31.40 | 31.40 | 30.90 | 30.90 | -0.5% | 13,000 |
| Oct 14, 2026 | 31.20 | 31.30 | 31.00 | 31.05 | -0.5% | 35,000 |
| Oct 13, 2026 | 31.20 | 31.20 | 31.20 | 31.20 | 0.0% | 12,000 |
| Oct 12, 2026 | 31.30 | 31.30 | 31.15 | 31.20 | -0.3% | 10,000 |
| Oct 8, 2026 | 31.30 | 31.40 | 31.10 | 31.30 | 0.0% | 16,000 |
| Oct 7, 2026 | 31.15 | 31.40 | 31.05 | 31.30 | +0.6% | 12,000 |
| Oct 6, 2026 | 31.20 | 31.20 | 30.90 | 31.10 | -0.3% | 10,000 |
| Oct 5, 2026 | 31.70 | 31.70 | 31.00 | 31.20 | — | 15,000 |
Prices in TWD from the Taipei Exchange; the last 30 trading days are listed, the chart shows up to ten years. For information only; not investment advice.
Level Biotechnology Inc. share price statistics
Changes compare closing prices; volatility is the annualised standard deviation of daily returns. Prices are as published by the exchange, not adjusted for splits, bonus issues or dividends. For information only; not investment advice.
Market cap history
World rank over time
Rank in Taiwan: #1,586 (Jan 2020) · #1,721 (Jan 2022) · #1,668 (Dec 2022) · #1,749 (Jul 2023) · #1,804 (Jan 2024) · #1,683 (Nov 2026) · #1,687 (Nov 2026) · #1,675 (Nov 2026) · #1,673 (Nov 2026) · #1,678 (Nov 2026) · #1,678 (Nov 2026)
How Level Biotechnology Inc. compares in Biotechnology
- Market cap$29 M · higher than 21% of 726
Peer comparison · Biotechnology
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Level Biotechnology Inc.🇹🇼 | $29 M | — | — | — |
| Novo Nordisk A/S🇩🇰 | $203.2 B | 13.1× | 33.1% | +10.8% |
| Vertex Pharmaceuticals Incorporated🇺🇸 | $134.3 B | 33.8× | 30.7% | +8.9% |
| Moderna, Inc.🇺🇸 | $90.1 B | — | -110.5% | -39.9% |
| Regeneron Pharmaceuticals, Inc.🇺🇸 | $84.1 B | 17.5× | 28.5% | +1.0% |
| Argenx SE🇳🇱 | $52.8 B | 40.9× | 31.1% | +89.9% |
| CSL Limited🇦🇺 | $51.6 B | — | -16.4% | — |
| Samsung Biologics Co., Ltd.🇰🇷 | $51.5 B | 40.5× | 39.2% | — |
| UCB SA🇧🇪 | $48.6 B | 26.3× | 20.1% | +31.1% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Compare head to head
Similar companies by size and industry
- Regenxbio Inc.$513 M
- Pharmicell Co., Ltd.$514 M
- Pulike Biological Engineering, Inc.$524 M
- Contineum Therapeutics, Inc.$534 M
- Entera Bio Ltd.$543 M
- Arvinas, Inc.$544 M
Sources and freshness
- Market cap:
- Nov 19, 2026
- Profile updated:
- Nov 20, 2026
Figures from Market data, value.today research.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Level Biotechnology Inc.? Verify and update this profile — free
Show Level Biotechnology Inc.'s ranking on your website Get the badge
The badge updates itself as the ranking changes.